Valuation: GKB Ophthalmics Limited

Market Cap 348M 3.71M 3.35M 3.09M 2.8M 5.28M 5.44M 37.13M 14.75M 186M 13.91M 13.61M 593M P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 421M 4.48M 4.05M 3.74M 3.38M 6.38M 6.57M 44.84M 17.82M 225M 16.8M 16.44M 716M EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
22.19%
Yield 2025 *
-
Yield 2026 -
11-13 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 CI
08-12 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
1 day-6.83%
1 week+9.77%
Current month+9.14%
1 month+8.53%
3 months-0.92%
6 months-0.92%
Current year+25.66%
1 week 58.78
Extreme 58.78
76
1 month 54
Extreme 54
76
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
76.9
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 58 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-6.83%+9.77%+5.51%-36.49% 3.71M
-1.87%-5.59%-16.74%+14.13% 186B
-0.61%-3.67%+5.41%+42.88% 124B
-2.01%-6.77%-14.96%+14.17% 119B
+0.64%-6.58%-43.40%+2.43% 91.43B
-0.14%+2.86%-3.86%+76.84% 66.67B
+0.55%+1.01%+12.28%-8.07% 58.76B
-0.65%+4.07%-2.18%+62.81% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-5.17%+0.55% - - 35.13B
Average -1.68%-0.44%-6.62%+24.88% 79B
Weighted average by Cap. -1.06%-3.37%-10.57%+27.59%

Financials

2025 2026
Net sales 1.09B 11.59M 10.48M 9.68M 8.76M 16.53M 17.02M 116M 46.16M 583M 43.51M 42.58M 1.85B 1.49B 15.86M 14.34M 13.24M 11.98M 22.61M 23.29M 159M 63.13M 797M 59.51M 58.24M 2.54B
Net income -70.45M -749K -678K -626K -566K -1.07M -1.1M -7.51M -2.98M -37.66M -2.81M -2.75M -120M 12.18M 130K 117K 108K 97.93K 185K 190K 1.3M 516K 6.51M 486K 476K 20.73M
Net Debt 15.59M 166K 150K 138K 125K 236K 244K 1.66M 660K 8.34M 622K 609K 26.53M 72.38M 770K 696K 643K 582K 1.1M 1.13M 7.71M 3.07M 38.7M 2.89M 2.83M 123M
Projected Income Statement - Annual - GKB Ophthalmics Limited
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
13/11/26 ₹64.39 -6.83% 8,175
12/11/26 ₹69.11 +10.05% 5,940
11/11/26 ₹62.80 +6.60% 51
09/11/26 ₹58.91 +0.43% 507
06/11/26 ₹58.66 -3.74% 444